4 weeks (2 vials): 6 mL 1 10 mL bottle 6 weeks (3 vials): 9 mL 1 10 mL bottle 8 weeks (4 vials): 12 mL 2 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each day
BPC-157 , also known as Body Protection Compound-157, is a synthetic pentadecapeptide developed in the early 1990s
In the p53 TAD apo state, most residues showed low values ( 0.2 was observed for residues corresponding to TAD2 and the C-terminus (Figure
Several factors support the theoretical viability of oral BPC-157, though human outcomes remain unproven: Gastric Stability: BPC-157 was originally studied for gastric protection in animal models, meaning the compound was administered directly into the stomach in research settings
A Multi-Faceted Ally in Recovery For those living with chronic Lyme disease, where pain, fatigue, and immune chaos dominate daily life, BPC-157 represents a multi-layered therapeutic option